Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BioCryst Pharmaceuticals Inc. June 11, 202697.3%
-
BioCryst Pharmaceuticals Inc. June 13, 202393.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 31, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +644 | $9.70 | $6,247 |
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| May 29, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +631 | $8.91 | $5,622 |
| May 18, 2026 | BioCryst Pharmaceuticals Inc. | Open-market sale | −11,180 | $8.97 | $100,285 |
| Feb 27, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +642 | $8.75 | $5,618 |
| Nov 28, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +783 | $7.18 | $5,622 |
| Aug 29, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +676 | $8.31 | $5,618 |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| Jun 24, 2024 | BioCryst Pharmaceuticals Inc. | Open-market sale | −8,600 | $6.32 | $54,352 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
Questions about Amy E. McKee
What boards is Amy E. McKee on?
Amy E. McKee sits on the board of BioCryst Pharmaceuticals Inc.
How long has Amy E. McKee served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.